Ownership history in UBS Group AG · 27 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in ARCTURUS THERAPEUTICS HLDG I (ARCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 227,893 | +67,407 | +42.0% | 0.00% | $1.4M | $6.13 |
| 2025 Q3 | ADDED | 160,486 | +140,586 | +706.5% | 0.00% | $3.0M | $18.43 |
| 2025 Q3 | REDUCED | 19,900 | -35,544 | -64.1% | 0.00% | $367K | $18.43 |
| 2025 Q2 | REDUCED | 55,444 | -4,100 | -6.9% | 0.00% | $721K | $13.01 |
| 2025 Q1 | ADDED | 59,544 | +6,473 | +12.2% | 0.00% | $631K | $10.59 |
| 2024 Q4 | ADDED | 53,071 | +213 | +0.4% | 0.00% | $901K | $16.97 |
| 2024 Q3 | REDUCED | 52,858 | -9,301 | -15.0% | 0.00% | $1.2M | $23.21 |
| 2024 Q2 | REDUCED | 62,159 | -45,780 | -42.4% | 0.00% | $1.5M | $24.35 |
| 2024 Q1 | ADDED | 107,939 | +35,231 | +48.5% | 0.00% | $3.6M | $33.77 |
| 2023 Q4 | ADDED | 72,708 | +41,446 | +132.6% | 0.00% | $2.3M | $31.53 |
As of 2025 Q4 — sorted by position size